Co-Authors
This is a "connection" page, showing publications co-authored by Christos Kyratsous and Neil Stahl.
Connection Strength
1.867
-
Reply to Dimitrov et al.: VelociSuite technologies are a foundation for rapid therapeutic antibody development. Proc Natl Acad Sci U S A. 2015 Sep 15; 112(37):E5116.
Score: 0.636
-
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies. Cell. 2021 07 22; 184(15):3949-3961.e11.
Score: 0.237
-
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science. 2020 11 27; 370(6520):1110-1115.
Score: 0.227
-
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science. 2020 08 21; 369(6506):1010-1014.
Score: 0.222
-
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science. 2020 08 21; 369(6506):1014-1018.
Score: 0.222
-
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2015 Jul 14; 112(28):8738-43.
Score: 0.157
-
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19. N Engl J Med. 2021 09 23; 385(13):1184-1195.
Score: 0.060
-
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. N Engl J Med. 2021 01 21; 384(3):238-251.
Score: 0.057
-
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets. Antiviral Res. 2018 08; 156:64-71.
Score: 0.048